Press Release

SARS-CoV-2 study kicks off in Germany

First participant enrolled in Phase III clinical trial of VPM1002 focused on healthcare workers battling the COVID-19 pandemic!

A competent partner at your side

Free first consulting session

We understand how complexe product development is, because we did it ourselves. Let us be a competent partner at your side for a secure route to a successful product.

From Bench to Product

Consulting and services

Speed up your development processes by using our expertise. We offer a comprehensive service portfolio covering all stages of pharmaceutical development.

About Vakzine Projekt Management

VPM offers tailor-made consultancy and services based on in-depth experience in development of biopharmaceutical candidates. As a client, you will benefit from the experience of our team in translational project management. This enables you to bring your development projects into clinical trials faster, more cost-effectively and with a higher probability of success.

The company was established in 2002. Within the last decade, VPM has successfully managed and consulted the development of promising biopharmaceutical candidates, ranging from small molecules, recombinant proteins up to gene-modified live vaccines and ATMPs. VPM brought these products for its customers in the pharmaceutical industry, academic research and small biotechnology companies, from preclinical phase through clinical phases I-III.

More about us

News & Press

News

SARS-CoV-2 study kicks off in Germany: First participant enrolled

Vakzine Projekt Management GmbH (VPM) announced that the first participant has been enrolled on May 25th in a phase III study to investigate whether the vaccine candidate VPM1002 is effective against respiratory disease like COVID-19 The large-scale study is initially to be carried out at several hospitals in Hanover, Munich, Erfurt and will soon include additional cities. The clinical trial will include healthcare workers which are particularly at risk from the disease. More!

News

First volunteer enrolled

Vakzine Projekt Management GmbH: First volunteer enrolled in Phase II/III Study of SIIPL Tdap vaccine in Comparison with Boostrix® in Healthy Participants. More!

Press

Modified TB vaccine as a therapy for bladder cancer

Press release on February 20, 2020: Modified tuberculosis vaccine as a therapy for cancer of the bladder. A therapy with VPM1002 is effective for bladder cancer patients. Please klick here for the whole release!

News

priMe AVAREF Meeting

The pivotal phase III infant vaccine trial was accepted by the African Vaccine Regulatory Forum (AVAREF) for a joint review process. The meeting has taken place from 22-24th of January 2020 in Nairobi, Kenya.

Consulting and services

Speed up your development processes by using our expertise. We offer a comprehensive service portfolio covering all stages of pharmaceutical development.

Our Method

Translational project management from the laboratory bench to clinical development.
powered by webEdition CMS